I happen to agree with uppitycats, as LDN is not FDA approved for MS and needs to be in a controlled study group....as I said before, it works for some and not for others. What concerns me most though is that MS disease activity still occurs while patients are deciding whether or not to go on LDN, and if they do but receive no benefits from it, this is time that they wasted, as MS is a progressive disease. Just my humble opinion though.
Lauren -- do you know anyone else on tysabri?
Yep, I sure do... too many to count as a matter of fact, because many MS patients have been e-mailing me regularly (since 6/06) with their Tysabri experiences and questions.
Tysabri Patient Progress Reports can also be found at: http://www.mspatientsforchoice.org/, and these reports are sent in monthly by the patients themselves, voluntarily.
To Shar, okay you're in Canada which makes sense as to why you are having trouble accessing Tysabri. As far as I know, Ontario is the only Providence were Tysabri is paid for by your NHS.
And the price that is listed on the website that I gave you is for the U.S. in U.S. currency. That website does not provide a list for the cost of Tysabri which was submitted to other countries.
Please note though that NICE for England and Wales' recently REVERSED their negative appraisal report of Tysabri, and are now recommending Tysabri to their NHS. Tysabri is the ONLY DMD for MS which has EVER been recommended to the NHS
and it will be costing approximately 14,000 pounds per year per patient.
This favorable decision will most likely help other MS patients in countries with socialized medicine. For example, the SMC for Scotland that previously denied Tysabri is in the process of reversing it's decision, and that's due out in August 2007 (as has been reported by the media).
I hope this information is of help to all of you.